The Leadership Team at oNKo-innate guides the strategic direction and vision of the company, focusing on innovative approaches to immuno-oncology drug development. Comprising the Co-founder & CEO, Principal Scientist, and Co-founder & CSO, the team leverages their expertise in Natural Killer (NK) cell biology to oversee research initiatives, foster collaborations, and drive the advancement of the company's therapeutic portfolio.